Figure 9. Microenvironmental effects HDAC1 and HMOX1 in liver cancer (A) Immunocytic infiltration analysis of two groups. (B) Methylation of HMOX1 in liver cancer. (C) Expression and Methylation of HMOX1 in clinical stage. (D) Expression and Methylation of HMOX1 in pathology grade. (E) Drug sensitivity analysis of Sorafenib, Regorafenib and Lenvatinib based on Oncopredict. (F) Drug sensitivity analysis of Cisplatin, Carboplatin, 5-Fluorouracil and Epirubicin based on Oncopredict. (G) TIDE Value in two groups. (H) Response to immunotherapy in two groups.